Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection/Experiment 3/Signature 1
From BugSigDB
< Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection | Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection/Experiment 3
Source: Figure 6A
Description: Results of the linear discriminant analysis effect size (LEfSe) analysis, showing the impact of BL21 treatment on differences in the abundance of bacterial taxa at the genus level. LEfSe analysis evaluates each significantly enriched bacterial taxonomic unit by calculating linear discriminant analysis (LDA) scores.
Abundance in Group 1: increased abundance in Bifidobacterium longum subsp. longum (BL21) group
| NCBI | Quality Control | Links |
|---|---|---|
| Bacteroides | ||
| Butyricicoccus | ||
| Lachnospiraceae UCG-010Lachnospiraceae UCG-010 | ||
| Muribaculum | ||
| Muribaculaceae | ||
| Lactobacillus | ||
| Bifidobacterium | ||
| Rikenella | ||
| Blautia | ||
| Actinomyces |
Revision editor(s): Victoria
